Business Standard

Tuesday, December 24, 2024 | 07:57 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covishield to cost Rs 200/dose for first 100 mn doses to govt: Serum CEO

MRP for private market Rs 1,000/ dose; current licence does not allow export or sale in private market

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute

Sohini Das Mumbai
As Serum Institute's Covishield vaccine gets the thumbs up from the Indian regulator, the Pune-based firm's CEO Adar Poonawalla speaks with Sohini Das on the road ahead. Poonawalla says he will start ramping up once he has clarity on the supply contracts as it is a challenge to stockpile beyond a certain volume in the plant. He also says that the special price of Rs 200 per dose is for the first 100 mn doses supplied to the government, while the MRP in the private market will be Rs 1,000 per dose. The current licence given to Serum Institute does

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in